Aug 21, 2025, 14:59
Primary APS: Warfarin INR 2.5–3.5 Lowers Thrombosis Recurrence, Especially Arterial Events
APS Support UK has shared a post on X:
“Study of 81 pts with primary APS on warfarin found those with INR 2.5–3.5 had reduced rethrombosis risk vs INR <2.5, esp. for arterial events.
Higher anticoagulation intensity = lower recurrence risk.”
Title: Recurrence of thrombosis in patients with primary antiphospholipid syndrome: Emphasis on arterial events
Authors: Antonio R Cabral, Alonso Turrent-Carriles, Irazu Contreras-Yáñez, Ariel Garcia-Torralba, Gabriela Hernandez-Molina
Read the full article here.
Stay updated with Hemostasis Today.
-
Jul 20, 2026, 13:18Ekaterina Balaian: Submission Open for Special Issue on Hematologic Metabolism
-
Jul 20, 2026, 12:54Victor Emmanuel: Preventing Severe Maternal Complications Associated With Anemia
-
Jul 20, 2026, 12:33Ney Carter Borges: The Evolving Role of Aspirin in Coronary Artery Disease
-
Jul 20, 2026, 12:15Zain Khalpey: Why the Cause of Reduced Perfusion Matters
-
Jul 20, 2026, 11:53ISTH 2026 Showcases Landmark Research and Launches Women’s Health Hub
-
Jul 20, 2026, 10:40Omid Seidizadeh: Advancing Genomic Insights into Bleeding Disorders at ISTH 2026
-
Jul 20, 2026, 10:30Marc Blondon: What Are the Current Practices For VTE Prevention in Pregnancy Worldwide?
-
Jul 20, 2026, 10:11Zeyad Bady: Advancing Thrombosis Research on the International Stage at ISTH 2026
-
Jul 20, 2026, 09:41Emily Bury: From Emerging Evidence to Better Patient Care at ISTH 2026